Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.06 | 0.7 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |